2017 Meeting Recordings (Members Only)

Use the search parameters below to filter talks:

Congress/Meeting:

Session Type:

Multimedia or Abstract:

Talk Title:

Date (start):

Date (end):

Presenter First name:

Presenter Last name:

Presenter City:

Presenter Country:

2017 - IPITA (Oxford)
Pancreas Transplantation - Outcomes & Complications 1 21 June 2017 / 11:00 - 12:30
International Pancreas Transplant Registry (IPTR) update Presenter: AC Gruessner, Syracuse, United States		- International Pancreas Transplant Registry (IPTR) update Presenter: AC Gruessner, Syracuse, United States
The Ultimate Benefit of Pancreas Transplantation: 183,982 Life-Years Saved according to UNOS/IPTR data Presenter: AC Gruessner, Syracuse, United States		- The Ultimate Benefit of Pancreas Transplantation: 183,982 Life-Years Saved according to UNOS/IPTR data Presenter: AC Gruessner, Syracuse, United States
Simultaneous Pancreas and Kidney Transplantation - Outcomes and predictors of long-term patient and graft survivals Presenter: Richard Allen, Westmead, Australia		- Simultaneous Pancreas and Kidney Transplantation - Outcomes and predictors of long-term patient and graft survivals Presenter: Richard Allen, Westmead, Australia
Influence of the Procurement Team on Pancreas Transplant Outcomes. Presenter: OK Serrano, Minneapolis, United States		- Influence of the Procurement Team on Pancreas Transplant Outcomes. Presenter: OK Serrano, Minneapolis, United States
The Case for Simultaneous Pancreas Kidney (SPK) Transplantation for Obese T2D Patients Presenter: Talal Al-Qaoud, Madison, United States		- The Case for Simultaneous Pancreas Kidney (SPK) Transplantation for Obese T2D Patients Presenter: Talal Al-Qaoud, Madison, United States
Simultaneous Pancreas and Kidney Transplant (SPK) – The New Standard of Care for Uremic Patients with Type 2 Diabetes Mellitus (T2DM)? Presenter: AC Gruessner, Syracuse, United States		- Simultaneous Pancreas and Kidney Transplant (SPK) – The New Standard of Care for Uremic Patients with Type 2 Diabetes Mellitus (T2DM)? Presenter: AC Gruessner, Syracuse, United States
Perioperative outcomes of functional β-cell function and insulin sensitivity of functioning pancreas transplants in patients with type 2 diabetes mellitus (T2DM) compared with type 1 diabetes mellitus (T1DM) Presenter: Duck Jong Han, , Korea		- Perioperative outcomes of functional β-cell function and insulin sensitivity of functioning pancreas transplants in patients with type 2 diabetes mellitus (T2DM) compared with type 1 diabetes mellitus (T1DM) Presenter: Duck Jong Han, , Korea
Glycemic Control after Pancreas Transplantation in Non-obese, Insulin-dependent Type 2 Diabetes Patients Presenter: P Abrams, Washington, United States		- Glycemic Control after Pancreas Transplantation in Non-obese, Insulin-dependent Type 2 Diabetes Patients Presenter: P Abrams, Washington, United States
Revisiting Pancreas after Kidney (PAK) Transplantation Presenter: Jonathan Fridell, Indianapolis, United States		- Revisiting Pancreas after Kidney (PAK) Transplantation Presenter: Jonathan Fridell, Indianapolis, United States
An analysis of outcomes after whole organ pancreas transplantation in recipients aged over 55 years Presenter: Shruti Mittal, Oxford, United Kingdom		- An analysis of outcomes after whole organ pancreas transplantation in recipients aged over 55 years Presenter: Shruti Mittal, Oxford, United Kingdom
Clinical Islet Allo-transplantation 1 21 June 2017 / 11:00 - 12:30
Intraomental Non-purified islet transplantation isolated from DCD donor pancreas Presenter: SW Wang, tianjin, People's Republic of China		- Intraomental Non-purified islet transplantation isolated from DCD donor pancreas Presenter: SW Wang, tianjin, People's Republic of China
Collaborative Islet Transplant Registry (CITR) update Presenter: Franca Barton, , United States		- Collaborative Islet Transplant Registry (CITR) update Presenter: Franca Barton, , United States
Donor insulin therapy in intensive care predicts early graft function/failure in pancreas and islet transplant recipients Presenter: I M Shapey, Manchester, United Kingdom		- Donor insulin therapy in intensive care predicts early graft function/failure in pancreas and islet transplant recipients Presenter: I M Shapey, Manchester, United Kingdom
National registry outcomes within the UK integrated islet transplant programme Presenter: Claire Counter, Bristol, United Kingdom		- National registry outcomes within the UK integrated islet transplant programme Presenter: Claire Counter, Bristol, United Kingdom
Relationships of time to second graft and total transplanted islet mass with 12-month graft function in an integrated national transplant programme. Presenter: Shareen Forbes, Edinburgh, United Kingdom		- Relationships of time to second graft and total transplanted islet mass with 12-month graft function in an integrated national transplant programme. Presenter: Shareen Forbes, Edinburgh, United Kingdom
Does islet size really influence graft function following clinical islet transplantation? Presenter: Steve Hughes, Oxford, United Kingdom		- Does islet size really influence graft function following clinical islet transplantation? Presenter: Steve Hughes, Oxford, United Kingdom
A comparative analysis of the clinical outcome of islet transplantation using donors after cardiac death versus intensive insulin therapy in patients with type 1 diabetes with severe hypoglycaemia unawareness: a 10-year follow-up at a single centre Presenter: T Anazawa, Kyoto, Japan		- A comparative analysis of the clinical outcome of islet transplantation using donors after cardiac death versus intensive insulin therapy in patients with type 1 diabetes with severe hypoglycaemia unawareness: a 10-year follow-up at a single centre Presenter: T Anazawa, Kyoto, Japan
Utilisation of Pancreata Declined for Solid Organ Transplant for Islet Cell Transplantation in Scotland Presenter: A Sutherland, Edinburgh, United Kingdom		- Utilisation of Pancreata Declined for Solid Organ Transplant for Islet Cell Transplantation in Scotland Presenter: A Sutherland, Edinburgh, United Kingdom
Persistent Graft Function Following Clinical Islet Transplantation In the Omentum Using a Biologic Scaffold Presenter: Rodolfo Alejandro, Miami, Florida, United States		- Persistent Graft Function Following Clinical Islet Transplantation In the Omentum Using a Biologic Scaffold Presenter: Rodolfo Alejandro, Miami, Florida, United States
Mini-laparotomy Mesenteric Vein Infusion vs. Percutaneous Transhepatic Portal Vein Infusion: Safety and Complication Rates during Clinical Islet Allograft Transplantation Presenter: Victor Vakayil, Minneapolis, United States		- Mini-laparotomy Mesenteric Vein Infusion vs. Percutaneous Transhepatic Portal Vein Infusion: Safety and Complication Rates during Clinical Islet Allograft Transplantation Presenter: Victor Vakayil, Minneapolis, United States
Display # 1 2 3 4 ... 10 Page 1 of 10

Return to TTS Section